A prognostic model integrating clinical information and gene expression signatures in phase III neoadjuvant trial CALGB 40601(Alliance).

Tanioka, Maki ,  Parker, Joel S ,  Henry, Lynn N ,  Tolaney, Sara ... -  JSMO   -  Ann Oncol   -  2018    

Abstract -  Secondary-not-in-original -  Primary -  Breast -  CALGB-40601